STSS - sharpstechnology.com Long-Term Liabilities to Capital

Symbol and logo of brand Sharps Technology (STSS)

The price action of Sharps Technology, Inc. (STSS) on GURU.Markets illustrates the brand's ambitions to implement next-generation safety syringes. Sharps Technology, Inc. (STSS) relies on significant pricing power by minimizing medication waste, which renders clinic demand inelastic. However, financial stability stands at 0.00, as innovation costs and a lack of profitability lead to depleted reserves and a search for external financing.

Sharps Technology (STSS): Long-Term Debt to Capital from 04/28/2023 to 05/28/2026
Core merchandise of Sharps Technology Inc

For Sharps Technology, Inc. (STSS), which implements innovative safety standards for injection systems, the balance between debt and equity determines the sustainability of investments in high-tech laboratories. Analyzing the long-term debt load chart on GURU.Markets, an investor assesses the proportion of loans with maturities exceeding one year relative to shareholders' equity, which helps identify the risk of excessive leverage and the probability of cash flow gaps amid rising interest rates.

Competitor analysis

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc.|Danaher Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Becton Dickinson & Company (BDX)|STE - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio westpharma.com WST|Long-Term Debt to Capital BAX (Baxter)|MASI - Ratio of Long-Term Indebtedness to Capital|STVN (Stevanato) - Long-Term Debt to Capital|Teleflex Corp (TFX) - Long-Term Debt to Equity Ratio|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital NVST|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity Dentsply Sirona Inc XRAY|Long-Term Debt to Equity Ratio LeMaitre|Long-Term Debt to Capital Coefficient AtriCure Medical ATRC|Long-Term Debt to Capital STAA (STAAR Surgical Company)|NAGE: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity ZimVie|ANGO (AngioDynamics Inc) - Long-Term Debt to Capital Ratio|CERS: Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Teknova Inc (TKNO)|Long-Term Debt to Equity Ratio Monogram Technologies|Long-Term Loans to Capital Ratio INFU (infusystem.com)|Long-Term Debt to Equity Utah Medical Products, Inc.|KRMD - Long-Term Debt to Capital Coefficient|Nyxoah, S.A. - Long-Term Debt to Equity Ratio|MBOT: Long-Term Debt to Capital|PDEX (Pro-Dex, Inc.) - Long-Term Debt to Equity|zentek.com (ZTEK) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital ELUT (Elutia)|Long-Term Liabilities to Capital MLSS|Long-Term Debt to Equity NEXGEL, Inc NXGL|Long-Term Debt to Capital Ratio retractable.com RVP|Long-Term Debt to Equity Ratio Harvard Bioscience, Inc. (HBIO)|femasys.com - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity MHUA (Meihua Medical)|POAI: Ratio of Long-Term Indebtedness to Capital|callanjmb.com - Long-Term Debt to Equity|Atrion Corporation Inc. (ATRI) - Ratio of Long-Term Indebtedness to Capital|NURO - Long-Term Debt to Capital